Can vaginal estradiol or moisturizer ease menopause symptoms in women with HIV?

NCT ID NCT07526948

First seen Jun 24, 2026 · Last updated Jul 29, 2026 · Updated 3 times

Summary

This study compares vaginal estradiol tablets (Vagifem) to a vaginal moisturizer (Replens) for treating menopause-related vaginal and urinary symptoms in women living with HIV. Researchers will also check how these treatments affect the vaginal microbiome. The study includes 62 participants, some with HIV and some without, and lasts 16 weeks.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
vaginal estradiol (Vagifem) and vaginal moisturizer (Replens)
What this could lead to
If it works, this could point toward a safe way to ease menopause symptoms and improve vaginal health in women living with HIV.
What could go wrong
This is a small, early-phase study with only 62 participants. Results may not apply to all women, and the benefits of estradiol or moisturizer may be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GENITOURINARY SYMPTOMS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Albert Einstein College of Medicine

    The Bronx, New York, 10461, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.